Among patients with acromegaly, women reported a significantly higher symptom burden, more musculoskeletal comorbidities, higher perceived need for treatment, and poorer physical and mental quality of ...

While the most obvious signs of acromegaly are changes to your facial features and unusual growth in your hands and feet, it also has effects no one else can see. This rare disease is caused by an ...

Learn how to manage persistent acromegaly symptoms after normal lab results, including monitoring, causes of lingering issues ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

Please provide your email address to receive an email when new articles are posted on . Adults diagnosed with acromegaly had 28% higher risk for any type of cancer compared with matched controls. Risk ...

Acromegaly is a rare but serious hormonal disorder caused by excess growth hormone, usually due to a benign tumour in the pituitary gland. It typically develops in adulthood and leads to noticeable ...

LAS VEGAS — The once-daily oral paltusotine (Palsonify, Crinetics Pharmaceuticals) showed efficacy and safety for the treatment of acromegaly in the first few patients to receive it post approval. And ...

Gigantism and acromegaly are growth disorders that result from excess amounts of growth hormone in the body. The conditions are similar but have several differences. Growth hormone is one of the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with acromegaly and concomitant type 2 diabetes ...

LUND, Sweden, April 25, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a ...